home / stock / inrlf / inrlf news

INRLF News and Press, Valneva Se Ord From 07/18/23

Stock Information
Company Name: Valneva Se Ord
Stock Symbol: INRLF
Market: OTC
Website: valneva.com
Menu
INRLF INRLF Quote INRLF Short INRLF News INRLF Articles INRLF Message Board
Get INRLF Alerts

News, Short Squeeze, Breakout and More Instantly...
INRLF - Valneva: VLA1553 Takes The Lead In The Chikungunya Vaccine Race

2023-07-18 04:17:27 ET Summary Positive Phase 3 data from Bavarian Nordic's chikungunya virus (CHIKV) vaccine candidate, PXVX0317, reinforces bullish view on Valneva's VLA1553 due to its superior clinical profile. Valneva's VLA1553 demonstrated impressive seroresponse rates and du...
INRLF - Valneva Supervisory Board Recommends Transition from a Two-Tier Governance Model to a Board of Directors

Saint - Herblain ( France), June 2 2 , 202 3 – Valneva S E (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its Supervisory Board has recommended a change of governance model. The Company’...

INRLF -   Valneva Announces Successful Outcome of its AGM and the Appointment of Pfizer's Former Vaccine R&D Head to its Supervisory Board

Saint - Herblain ( France), June 2 1 , 202 3 – Valneva S E (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were approved by the shareholders ...

INRLF - Valneva Announces Publication of its Chikungunya Vaccine Candidate Phase 3 Data in The Lancet

Saint- Herb lain (France ) , June 13 , 2 02 3 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that the Company’s pivotal Phase 3 data for its single-shot chikungunya vaccine candidate, V...
INRLF - Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June

Saint- Herb lain (France) , May 31 , 2 02 3 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will attend the Jefferies Healthcare Conference (June 7-9 in New York), Go...

INRLF - Valneva Announces the Availability of Documentation for its Shareholder Meeting

Saint-Herb lain (France ) , May 3 1 , 2 02 3 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the availability of documentation for its Combined General Meeting to be held on June 21, 2023 at 2 ...

INRLF - Valneva Files for Chikungunya Vaccine Authorization with Health Canada

Saint- Herb lain (France ) , May 30 , 2 02 3 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces the filing of a regulatory application with Health Canada for marketing approval of the Company&...
INRLF - Valneva SE (VALN) Q1 2023 Earnings Call Transcript

2023-05-06 22:10:49 ET Valneva SE (VALN) Q1 2023 Earnings Conference Call May 04, 2023, 09:00 ET Company Participants Joshua Drumm - VP, IR Thomas Lingelbach - Chairman, President & CEO Peter Buhler - CFO Conference Call Participants Kevin Strang ...

INRLF - Valneva Reports First Quarter 2023 Financial Results and Provides Corporate Updates

Product sales increased 98.6% to €3 2 . 1 million in the first quarter of 202 3 compared to € 16 . 2 million in the first quarter of 2022 Driven by IXIARO ® and DUKORAL ® sales both...

INRLF - Valneva Announces Filing of 2022 Universal Registration Document and US Form 20-F

Saint - Herblain ( France), March 31 , 20 2 3 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 30 2023, of its 2022 Universal Registration Document (URD) with the French Financi...
Previous 10 Next 10